Filing Details
- Accession Number:
- 0001367644-20-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-02 17:28:48
- Reporting Period:
- 2020-02-27
- Accepted Time:
- 2020-03-02 17:28:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403769 | Sue Bailey | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-27 | 6,572 | $56.93 | 39,761 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan, as amended.
- The price reported is the weighted average sale price. These shares were sold in multiple transactions in prices ranging from $56.50 to $57.49.
Billionaire Hedge Funds
